Posted by Michael Wonder on 19 Apr 2017
In the debate over rising drug prices, both drug makers and PBMs claim innocence
19 April 2017 - The battle over rising drug prices has become a full-blown he-said-she-said.
Drug companies have pointed the finger at middlemen in the health-care system, saying they not only benefit from rising drug prices but contribute to their increases.
Those middlemen — namely, pharmacy benefits managers — have said the only parties responsible for drugs' list prices are the manufacturers.
So who's right?
